People
Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.
Renowned Cancer Researcher to Support Ongoing Clinical Studies to Further Demonstrate the Safety and Efficacy of NAD+
MetrioPharm AG, a pharmaceutical development company, welcomes Sven Zimmermann, as its new Chief Financial Officer, bringing more than a decade of experience in strategic transactions.
InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer’s, CTE and other related Dementias.
Appointments of Rolf Soderstrom and Dr Jim Esinhart as Non-Executive Directors
For John Cumbers, chief executive officer of SynBioBeta, turning rural America into a biotech hotbed may be an answer to kick start the local economies and advance new products that could benefit the nation and world.
Novartis Chief Executive Officer Vas Narasimhan is excited about the company’s progress through the first half of 2019 and expects that momentum to continue with a “catalyst-rich” second half of the year.
A three-judge panel ruled against Shkreli’s appeals team, claiming that the trial judge’s directions were clear and within the law.
Acacia’s founder will continue on in an advisory role while ViiV’s departing CSO is eying multiple opportunities.
Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience, appointed as Executive Chairman of Botanix Pharmaceuticals
PRESS RELEASES